Related Experiment Video
Updated: Jun 6, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Effects of Multilevel and Multidomain Interventions on Glycemic Control Among Black Persons with Type 2 Diabetes in
Fawsia Osman1, Cherry Jiang1, Amber N Deckard1
1Department of Medicine, University of Chicago, Chicago, IL, USA.
Background:
Type 2 diabetes (T2D) disproportionately affects Black individuals in the U.S., who have higher rates of complications and worse glycemic control. This systematic review and meta-analysis evaluated the effectiveness of non-pharmacological interventions on hemoglobin A1c (HbA1c) in this population.
Methods:
We searched PubMed, Scopus, PsycInfo, and CINAHL for randomized controlled trials (RCTs) (1985-2019) enrolling ≥ 50% Black/African American adults with T2D or reporting race-specific HbA1c outcomes, with ≥ 3 months' follow-up. Interventions were classified by levels and domains of influence using the National Institute on Minority Health and Health Disparities framework. Risk of bias and evidence certainty were assessed using Cochrane and GRADE. A random-effects meta-analysis estimated the weighted mean difference (WMD) in HbA1c.
Results:
Forty-six RCTs (7,864 participants) met criteria. Interventions significantly reduced HbA1c (WMD - 0.38%; 95% CI - 0.51 to - 0.25; I²=50%, τ²=0.08). Multi-domain interventions achieved the largest reductions (- 0.43%; 95% CI - 0.60 to - 0.25; I²=53%, τ²=0.08). Risk of bias was low, and strength of evidence was high. No interventions addressed community/societal levels or the physical/built environment.
Discussion:
Interventions significantly improved glycemic control among Black adults with T2D. These findings underscore the importance of comprehensive, culturally tailored approaches to diabetes self-management support. Further research is needed on structural interventions to address disparities.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes I: Introduction